Pharmaceutical stocks slide as Trump vows to cut US prescription drug prices ‘by 30-80%'
1. Trump aims to cut US prescription drug prices by 30% to 80%. 2. His proposed policy could harm pharmaceutical stock profits significantly. 3. European and US pharmaceutical shares declined sharply following his announcement. 4. Concerns arise over potential government price-setting impacts on drug firms. 5. Previous price cap attempts faced legal challenges and policy conflicts.